NCT06904313View on ClinicalTrials.gov

Ultralow Dose PET Imaging for PSMA Expression

PHASE2RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

May 12, 2025

Primary Completion Date

June 30, 2030

Study Completion Date

June 30, 2030

Conditions
Healthy VolunteerProstate CA
Interventions
DRUG

Piflufolastat F18

Participants will be injected with Piflufolastat F18 and imaged for up to 3 hours on a PET scanner

Trial Locations (1)

07631

RECRUITING

Nuclear Imaging Institute, Englewood

All Listed Sponsors
lead

Akiva Mintz

OTHER